162 related articles for article (PubMed ID: 23789722)
1. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.
Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ
Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722
[TBL] [Abstract][Full Text] [Related]
2. Cerebral MRI abnormalities associated with vigabatrin therapy.
Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
[TBL] [Abstract][Full Text] [Related]
3. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
[TBL] [Abstract][Full Text] [Related]
4. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
Schonstedt V; Stecher X; Venegas V; Silva C
Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
[TBL] [Abstract][Full Text] [Related]
6. Vigabatrin for infantile spasms.
Mitchell WG; Shah NS
Pediatr Neurol; 2002 Sep; 27(3):161-4. PubMed ID: 12393124
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.
Wheless JW; Carmant L; Bebin M; Conry JA; Chiron C; Elterman RD; Frost M; Paolicchi JM; Donald Shields W; Thiele EA; Zupanc ML; Collins SD
Epilepsia; 2009 Feb; 50(2):195-205. PubMed ID: 19054414
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin-associated brain abnormalities on MRI and other neurological symptoms in patients with West syndrome.
Reyes Valenzuela G; Crespo A; Princich J; Fassulo L; Semprino M; Gallo A; Rugilo C; Pociecha J; Calvo A; Caraballo RH
Epilepsy Behav; 2022 Apr; 129():108606. PubMed ID: 35180571
[TBL] [Abstract][Full Text] [Related]
9. Globus pallidus restricted diffusion associated with vigabatrin therapy.
Trindade RAR; Wainstein B; Campos LG; Pérez JA; Bianchin MM; Vedolin LM; Duarte JÁ
Arq Neuropsiquiatr; 2018 Feb; 76(2):127-128. PubMed ID: 29489970
[No Abstract] [Full Text] [Related]
10. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
[No Abstract] [Full Text] [Related]
11. The vigabatrin-associated brain abnormalities on MRI and their differential diagnosis.
Corrêa DG; Telles B; Freddi TAL
Clin Radiol; 2024 Feb; 79(2):94-101. PubMed ID: 38092645
[TBL] [Abstract][Full Text] [Related]
12. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
13. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
Dill P; Datta AN; Weber P; Schneider J
Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin administration in patients with infantile spasms: the risks.
Jaseja H
Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
[No Abstract] [Full Text] [Related]
15. Fulminant vigabatrin toxicity during combination therapy with adrenocorticotropic hormone for infantile spasms: Three cases and review of the literature.
Bhalla S; Skjei K
Epilepsia; 2020 Oct; 61(10):e159-e164. PubMed ID: 32944947
[TBL] [Abstract][Full Text] [Related]
16. Brain MRI findings with vigabatrin therapy: case report and literature review.
Hussain K; Walsh TJ; Chazen JL
Clin Imaging; 2016; 40(1):180-2. PubMed ID: 26526789
[TBL] [Abstract][Full Text] [Related]
17. Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study.
Riikonen R; Rener-Primec Z; Carmant L; Dorofeeva M; Hollody K; Szabo I; Krajnc BS; Wohlrab G; Sorri I
Dev Med Child Neurol; 2015 Jan; 57(1):60-7. PubMed ID: 25145415
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of vigabatrin in patients with infantile spasms.
Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
[TBL] [Abstract][Full Text] [Related]
19. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
Lotan E; Bluvstein J; Zan E
Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
[No Abstract] [Full Text] [Related]
20. [Reversible alterations in the neuroimages associated with vigabatrine treatment in infants with epileptic spasms].
Fernandez-Garcia MA; Garcia-Penas JJ; Gomez-Martin H; Perez-Sebastian I; Garcia-Esparza E; Sirvent-Cerda S
Rev Neurol; 2017 Feb; 64(4):169-174. PubMed ID: 28169412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
